Villeneuve, S., J. Vogel, J. Gonneaud, B. Pichet, P. Rosa-Neto, S. Gauthier, R. Bateman, A. Fagan, J. Morris, T. Benzinger, S. Johnson, J. Breitner, J. Poirier, and E. Presymptomatic. “Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.”. JAMA Neurology, Vol. 75, no. 5, 2018, pp. 608-19.
Alzheimer disease (AD) develops during several decades. Presymptomatic individuals might be the best candidates for clinical trials, but their identification is challenging because they have no symptoms.
DOI: 10.1001/jamaneurol.2017.5135
PubMed: 29482212